PSMA expression has also been reliably demonstrated in normal and hyperplastic prostate tissue, prostatic intraepithelial neoplasia, and invasive carcinomas using immunohistochemistry (IHC) and other techniques [7,8,9]. Here, FOLH1 is linked to invasive carcinoma.